All VTRS Content

Viatris Inc (VTRS) Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Viatris Inc (NASDAQ: VTRS) FY 2026 Other Release

April 10, 20261 min read

Viatris Inc (VTRS) Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

Viatris Inc (NASDAQ: VTRS) FY 2026 Other Release

March 23, 20261 min read

Viatris Inc (VTRS) Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030

Viatris Inc (NASDAQ: VTRS) FY 2026 Other Release

March 19, 20261 min read

Viatris Inc (VTRS) Q4 2025 Earnings Call Transcript

Viatris Inc (NASDAQ: VTRS) Q4 2025 Earnings Call dated Feb. 26, 2026 Corporate Participants: Operator Bill Szablewski — Head of...

March 10, 202645 min read

Viatris Inc (VTRS) Sec Form 10K

Viatris Inc (NASDAQ: VTRS) Sec Form 10K

February 28, 20261 min read

Viatris Inc (VTRS) Sec Form 8K

Viatris Inc (NASDAQ: VTRS) Sec Form 8K

February 28, 20261 min read

Viatris Inc (VTRS) Dividend Update

Viatris Inc (NASDAQ: VTRS) Q1 2026 Dividend Update

February 26, 20261 min read

Viatris Inc (VTRS) Q4 2025 Earnings Results

Viatris Inc (NASDAQ: VTRS) Q4 2025 Earnings Release

February 26, 20261 min read

Viatris Inc (VTRS) Q4 2025 Earnings Call

Viatris Inc (NASDAQ: VTRS) Q4 2025 Earnings Conference

February 26, 20261 min read

Viatris Inc (VTRS) FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia

Viatris Inc (NASDAQ: VTRS) FY 2026 Other Release

February 25, 20261 min read